Works matching AU Nakagawa, Kazuhiko

Results: 278
    1

    Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).

    Published in:
    2018
    By:
    • Akito Hata;
    • Nobuyuki Katakami;
    • Mototsugu Shimokawa;
    • Tetsuya Mitsudomi;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawa;
    • Hata, Akito;
    • Katakami, Nobuyuki;
    • Shimokawa, Mototsugu;
    • Mitsudomi, Tetsuya;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    2
    3
    4

    Progression-Free and Overall Survival of Patients With ALK Rearrangement-Positive Non-Small Cell Lung Cancer Treated Sequentially With Crizotinib and Alectinib.

    Published in:
    2016
    By:
    • Satomi Watanabe;
    • Hidetoshi Hayashi;
    • Kunio Okamoto;
    • Kimiko Fujiwara;
    • Yoshikazu Hasegawa;
    • Hiroyasu Kaneda;
    • Kaoru Tanaka;
    • Masayuki Takeda;
    • Kazuhiko Nakagawa;
    • Watanabe, Satomi;
    • Hayashi, Hidetoshi;
    • Okamoto, Kunio;
    • Fujiwara, Kimiko;
    • Hasegawa, Yoshikazu;
    • Kaneda, Hiroyasu;
    • Tanaka, Kaoru;
    • Takeda, Masayuki;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    5

    Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation- Positive Metastatic Non—Small-Cell Lung Cancer.

    Published in:
    2017
    By:
    • Garon, Edward B.;
    • Reck, Martin;
    • Paz-Ares, Luis;
    • Ponce, Santiago;
    • Jaime, Jesus Corral;
    • Juan, Oscar;
    • Nadal, Ernest;
    • Lee, Pablo;
    • Dalai, Rita;
    • Jingyi Liu;
    • Shuang He;
    • Treat, Joseph;
    • Kazuhiko Nakagawa;
    • Dalal, Rita;
    • Liu, Jingyi;
    • He, Shuang;
    • Nakagawa, Kazuhiko
    Publication type:
    journal article
    6
    7
    8
    9
    10

    Mechanism of carcinogenesis in familial tumors.

    Published in:
    International Journal of Clinical Oncology, 2004, v. 9, n. 4, p. 232, doi. 10.1007/s10147-004-0430-4
    By:
    • Tamura, Kazuo;
    • Utsunomiya, Joji;
    • Iwama, Takeo;
    • Furuyama, Jun-ichi;
    • Takagawa, Tetsuya;
    • Takeda, Naohisa;
    • Fukuda, Yoshihiro;
    • Matsumoto, Takayuki;
    • Nishigami, Takashi;
    • Kusuhara, Kiyoshi;
    • Sagayama, Ken;
    • Nakagawa, Kazuhiko;
    • Yamamura, Takehira
    Publication type:
    Article
    11

    Review of 200 Stapled Functional End-to-End Anastomoses.

    Published in:
    Digestive Surgery, 1993, v. 10, n. 5, p. 245, doi. 10.1159/000172185
    By:
    • Kusunoki, Masato;
    • Yanagi, Hidenori;
    • Sakanoue, Youichirou;
    • Shoji, Yasutsugu;
    • Nakagawa, Kazuhiko;
    • Yamamura, Takehira;
    • Utsunomiya, Joji
    Publication type:
    Article
    12
    13

    Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 3, p. 214, doi. 10.1016/j.cllc.2022.01.005
    By:
    • Govindan, Ramaswamy;
    • Lind, Mike;
    • Insa, Amelia;
    • Khan, Saad A.;
    • Uskov, Dmitry;
    • Tafreshi, Ali;
    • Guclu, Salih;
    • Bar, Jair;
    • Terufumi Kato;
    • Ki Hyeong Lee;
    • Kazuhiko Nakagawa;
    • Hansen, Olfred;
    • Biesma, Bonne;
    • Kundu, Madan G.;
    • Dunbar, Martin;
    • Lei He;
    • Ansell, Peter;
    • Sehgal, Vasudha;
    • Xin Huang;
    • Glasgow, Jaimee
    Publication type:
    Article
    14

    Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non–small-cell Lung Cancer: SQUAT trial (WJOG 12119L).

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 6, p. 596, doi. 10.1016/j.cllc.2021.04.006
    By:
    • Hamada, Akira;
    • Soh, Junichi;
    • Hata, Akito;
    • Nakamatsu, Kiyoshi;
    • Shimokawa, Mototsugu;
    • Yatabe, Yasushi;
    • Oizumi, Hiroyuki;
    • Tsuboi, Masahiro;
    • Horinouchi, Hidehito;
    • Yoshino, Ichiro;
    • Tanahashi, Masayuki;
    • Toyooka, Shinichi;
    • Okada, Morihito;
    • Yokomise, Hiroyasu;
    • Yamashita, Motohiro;
    • Nishimura, Yasumasa;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Mitsudomi, Tetsuya
    Publication type:
    Article
    15

    A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
    By:
    • Takeda, Masayuki;
    • Shimokawa, Mototsugu;
    • Nakamura, Atsushi;
    • Nosaki, Kaname;
    • Watanabe, Yasutaka;
    • Kato, Terufumi;
    • Hayakawa, Daisuke;
    • Tanaka, Hiroshi;
    • Takahashi, Toshiaki;
    • Kogure, Yoshihito;
    • Tachihara, Motoko;
    • Fujimoto, Daichi;
    • Yamaguchi, Kakuhiro;
    • Hamaguchi, Naohiko;
    • Okamoto, Isamu;
    • Azuma, Koichi;
    • Hasegawa, Kazuo;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    16
    17

    Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

    Published in:
    2020
    By:
    • Shiraishi, Yoshimasa;
    • Kishimoto, Junji;
    • Tanaka, Kentaro;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirano, Katsuya;
    • Azuma, Koichi;
    • Hataji, Osamu;
    • Hayashi, Hidetoshi;
    • Tachihara, Motoko;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Okamoto, Isamu
    Publication type:
    journal article
    18
    19
    20
    21
    22

    A Randomized Phase II Study Comparing Nivolumab With Carboplatin-Pemetrexed for Patients With EGFR Mutation-Positive Nonsquamous Non-Small-Cell Lung Cancer Who Acquire Resistance to Tyrosine Kinase Inhibitors Not Due to a Secondary T790M Mutation: Rationale and Protocol Design for the WJOG8515L Study.

    Published in:
    2017
    By:
    • Hidetoshi Hayashi;
    • Yasutaka Chiba;
    • Kazuko Sakai;
    • Tomonobu Fujita;
    • Fiiroshige Yoshioka;
    • Daisuke Sakai;
    • Chiyoe Kitagawa;
    • Tateaki Naito;
    • Koji Takeda;
    • Isamu Okamoto;
    • Tetsuya Mitsudomi;
    • Yutaka Kawakami;
    • Kazuto Nishio;
    • Shinichiro Nakamura;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawa;
    • Hayashi, Hidetoshi;
    • Chiba, Yasutaka;
    • Sakai, Kazuko;
    • Fujita, Tomonobu
    Publication type:
    journal article
    23
    24
    25
    26
    27
    28
    29
    30

    Dual single‑nucleotide polymorphism biomarker combination for opioid selection to treat cancer pain.

    Published in:
    Molecular & Clinical Oncology, 2025, v. 22, n. 2, p. N.PAG, doi. 10.3892/mco.2024.2809
    By:
    • Fujita, Yoshihiko;
    • Matsuoka, Hiromichi;
    • Chiba, Yasutaka;
    • Tsurutani, Junji;
    • Yoshida, Takeshi;
    • Sakai, Kiyohiro;
    • Nakura, Miki;
    • Sakamoto, Ryo;
    • Makimura, Chihiro;
    • Ohtake, Yoichi;
    • Tanaka, Kaoru;
    • Hayashi, Hidetoshi;
    • Takahama, Takayuki;
    • Tanizaki, Junko;
    • Koyama, Atsuko;
    • Nishio, Kazuto;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38

    Updated Overall Survival in a Randomized Study Comparing Dacomitinib with Gefitinib as First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

    Published in:
    Drugs, 2021, v. 81, n. 2, p. 257, doi. 10.1007/s40265-020-01441-6
    By:
    • Mok, Tony S.;
    • Cheng, Ying;
    • Zhou, Xiangdong;
    • Lee, Ki Hyeong;
    • Nakagawa, Kazuhiko;
    • Niho, Seiji;
    • Chawla, Alka;
    • Rosell, Rafael;
    • Corral, Jesus;
    • Migliorino, Maria Rita;
    • Pluzanski, Adam;
    • Noonan, Kay;
    • Tang, Yiyun;
    • Pastel, Malaika;
    • Wilner, Keith D.;
    • Wu, Yi-Long
    Publication type:
    Article
    39
    40

    Prognostic impact of geriatric assessment in elderly patients with non-small cell lung cancer: an integrated analysis of two randomized phase III trials (JCOG1115-A).

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 685, doi. 10.1093/jjco/hyaa257
    By:
    • Katayama, Hiroshi;
    • Mizusawa, Junki;
    • Fukuda, Haruhiko;
    • Nakamura, Shinichiro;
    • Nakamura, Kenich;
    • Saijo, Nagahiro;
    • Yokoyama, Akira;
    • Ohe, Yuichro;
    • Shinkai, Tetsu;
    • Nakagawa, Kazuhiko;
    • Abe, Tetsuya;
    • Mitsuoka, Shigeki;
    • Okamoto, Hiroaki;
    • Yamamoto, Nobuyuki;
    • Yoshioka, Hiroshige;
    • Ando, Masahiko;
    • Tamura, Tomohide;
    • Takeda, Koji
    Publication type:
    Article
    41

    Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 1, p. 106, doi. 10.1093/jjco/hyaa157
    By:
    • Saka, Hideo;
    • Nishio, Makoto;
    • Hida, Toyoaki;
    • Nakagawa, Kazuhiko;
    • Sakai, Hiroshi;
    • Nogami, Naoyuki;
    • Atagi, Shinji;
    • Takahashi, Toshiaki;
    • Horinouchi, Hidehito;
    • Takenoyama, Mitsuhiro;
    • Katakami, Nobuyuki;
    • Tanaka, Hiroshi;
    • Takeda, Koji;
    • Satouchi, Miyako;
    • Isobe, Hiroshi;
    • Maemondo, Makoto;
    • Goto, Koichi;
    • Hirashima, Tomonori;
    • Minato, Koichi;
    • Yada, Nobumichi
    Publication type:
    Article
    42

    Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).

    Published in:
    Japanese Journal of Clinical Oncology, 2019, v. 49, n. 10, p. 947, doi. 10.1093/jjco/hyz088
    By:
    • Kimura, Tatsuo;
    • Kawaguchi, Tomoya;
    • Chiba, Yasutaka;
    • Yoshioka, Hiroshige;
    • Watanabe, Katsuya;
    • Kijima, Takashi;
    • Kogure, Yoshihito;
    • Oguri, Tetsuya;
    • Yoshimura, Naruo;
    • Niwa, Takashi;
    • Kasai, Takashi;
    • Hayashi, Hidetoshi;
    • Ono, Akira;
    • Asai, Kazuhisa;
    • Tanaka, Hiroshi;
    • Yano, Seiji;
    • Yamamoto, Nobuyuki;
    • Nakanishi, Yoichi;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.

    Published in:
    PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0121891
    By:
    • Sakai, Kazuko;
    • Tsurutani, Junji;
    • Yamanaka, Takeharu;
    • Yoneshige, Azusa;
    • Ito, Akihiko;
    • Togashi, Yosuke;
    • De Velasco, Marco A.;
    • Terashima, Masato;
    • Fujita, Yoshihiko;
    • Tomida, Shuta;
    • Tamura, Takao;
    • Nakagawa, Kazuhiko;
    • Nishio, Kazuto
    Publication type:
    Article
    50